COMP <GO>
BCPC vs NEM // RETURN ON INVESTED CAPITAL (ROIC)
Balchem Corporation (NASDAQ) VS. Newmont Corporation (NYSE) • 15-METRIC TALLY: BCPC 2
— NEM 10
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: NEM
LAST: $170.40 (+2.47%) • MKT CAP: $5.41B
roic
14.00%
LAST: $111.80 (-1.86%) • MKT CAP: $116.18B
roic
21.80%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BCPC VS. NEM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BCPC | NEM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 35.70% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 14.00% | 21.80% | -7.80 | NEM | /roic <GO> |
| EV/EBITDA & P/E Valuation | 25.5x | 11.9x | +13.60 | NEM | /valuation <GO> |
| Free Cash Flow Yield | 4.00% | 8.02% | -4.02 | NEM | /fcf-yield <GO> |
| Operating Margin | 20.20% | 38.10% | -17.90 | NEM | /operating-margins <GO> |
| Net Profit Margin | 14.90% | 31.30% | -16.40 | NEM | /net-margins <GO> |
| Revenue Growth (YoY) | 8.80% | 21.30% | -12.50 | NEM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.52% | 0.95% | -0.43 | NEM | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 9.67 | 4.16 | +5.51 | BCPC | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 9/9 | -1.00 | NEM | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 50.4 | 45.4 | +5.03 | BCPC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.04 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 32.6x | 13.8x | +18.80 | NEM | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.41B | $116.18B | -$110.77B | NEM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BCPC REV | NEM REV | BCPC GROSS % | NEM GROSS % | BCPC FCF | NEM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.04B | $22.67B | 35.7% | — | $216.6M | $9.31B |
| FY 2024 | $953.7M | $18.68B | 35.3% | — | $182.0M | $5.52B |
| FY 2023 | $922.4M | $11.81B | — | — | $183.8M | $2.23B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BCPC // BETA —
NEM // BETA 1.04